Arq Inc. (ARQ) Insider Trading

Last 12 months

Insiders bought $907k and sold $38k on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Chief Financial Officer Jay Loring Voncannon sold $38k on May 4, 26% of their stake, outside a plan.

Net open-market

+$870k

10 buys · 1 sale

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

7 / 1

executives and directors

Last open-market buy

Sep 2026

Sep 8, 2026

Get an email when ARQ's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Sep 8	Shimon Steinmetz Chief Financial Officer	Bought 2 parts	2,972	$2.34 average	$7k	0.8%	Form 4
Sep 4	Shimon Steinmetz Chief Financial Officer	Bought 2 parts	5,758	$2.27 average	$13k	1.6%	Form 4
Sep 3	Shimon Steinmetz Chief Financial Officer	Bought 2 parts	16,270	$2.23 average	$36k	4.7%	Form 4
May 4	Jay Loring Voncannon Chief Financial Officer	SoldNo plan	16,709	$2.27	$38k	26%	Form 4
Mar 23	Richard Campbell-Breeden Director	Bought	150,000	$2.21	$332k	44%	Form 4
Mar 17	Joseph M Wong Chief Technology Officer	Bought	10,000	$1.89	$19k	2.6%	Form 4
Mar 12 – 16	Claiborne Benson Smith Gen Counsel, Corp Secretary	Bought 2 parts	2,000	$1.92 average	$4k	2.0%	Form 4
Mar 13	Carol S Eicher Director	Bought	77,500	$1.95	$151k	80%	Form 4
Nov 10, 2025 – Nov 11, 2025	Jay Loring Voncannon Chief Financial Officer	Bought 2 parts	15,000	$3.66 average	$55k	30%	Form 4
Nov 11, 2025	Richard Campbell-Breeden Director	Bought	28,638	$3.54	$101k	9.1%	Form 4
Nov 10, 2025	Robert E. Rasmus Chief Executive Officer	Bought	50,000	$3.79	$190k	4.9%	Form 4
Aug 4, 2025	Joseph M Wong Chief Technology Officer	SoldNo plan	3,052	$5.20	$16k	0.8%	Form 4
Aug 4, 2025	Claiborne Benson Smith Gen Counsel, Corp Secretary	SoldNo plan	2,591	$5.20	$13k	3.0%	Form 4
Aug 4, 2025	Stacia Hansen Chief Accounting Officer	SoldNo plan	2,742	$5.20	$14k	3.6%	Form 4
Aug 4, 2025	Jeremy Williamson Chief Operating Officer	SoldNo plan	1,782	$5.20	$9k	1.3%	Form 4
May 23, 2025	Robert E. Rasmus Chief Executive Officer	Bought	25,000	$4.10	$103k	2.5%	Form 4
May 23, 2025	Jeremy Blank Director	Bought	50,000	$4.10	$205k	2.1%	Form 4
May 23, 2025	Richard Campbell-Breeden Director	Bought	75,000	$4.10	$308k	36%	Form 4
May 16, 2025	Joseph M Wong Chief Technology Officer	Bought	16,000	$4.61	$74k	4.5%	Form 4
May 13, 2025 – May 14, 2025	Robert E. Rasmus Chief Executive Officer	Bought 2 parts	15,456	$3.94 average	$61k	1.6%	Form 4
May 12, 2025	Jeremy Williamson Chief Operating Officer	Bought	400	$4.02	$2k	0.3%	Form 4
May 9, 2025 – May 12, 2025	Robert E. Rasmus Chief Executive Officer	Bought 2 parts	5,262	$3.96 average	$21k	0.5%	Form 4
Mar 24, 2025	Stacia Hansen Chief Accounting Officer	SoldNo plan	3,557	$4.68	$17k	4.5%	Form 4
Mar 24, 2025	Claiborne Benson Smith Gen Counsel, Corp Secretary	SoldNo plan	5,202	$4.68	$24k	5.8%	Form 4
Mar 24, 2025	Jeremy Williamson Chief Operating Officer	SoldNo plan	5,233	$4.68	$24k	3.6%	Form 4
Mar 24, 2025	Joseph M Wong Chief Technology Officer	SoldNo plan	6,596	$4.68	$31k	1.8%	Form 4

Sep 8
Shimon Steinmetz
Chief Financial Officer · bought 2,972 at avg $2.34
$7k
0.8% of stake
Sep 4
Shimon Steinmetz
Chief Financial Officer · bought 5,758 at avg $2.27
$13k
1.6% of stake
Sep 3
Shimon Steinmetz
Chief Financial Officer · bought 16,270 at avg $2.23
$36k
4.7% of stake
May 4No plan
Jay Loring Voncannon
Chief Financial Officer · sold 16,709 at $2.27
$38k
26% of stake
Mar 23
Richard Campbell-Breeden
Director · bought 150,000 at $2.21
$332k
44% of stake
Mar 17
Joseph M Wong
Chief Technology Officer · bought 10,000 at $1.89
$19k
2.6% of stake
Mar 12 – 16
Claiborne Benson Smith
Gen Counsel, Corp Secretary · bought 2,000 at avg $1.92
$4k
2.0% of stake
Mar 13
Carol S Eicher
Director · bought 77,500 at $1.95
$151k
80% of stake
Nov 10, 2025 – Nov 11, 2025
Jay Loring Voncannon
Chief Financial Officer · bought 15,000 at avg $3.66
$55k
30% of stake
Nov 11, 2025
Richard Campbell-Breeden
Director · bought 28,638 at $3.54
$101k
9.1% of stake
Nov 10, 2025
Robert E. Rasmus
Chief Executive Officer · bought 50,000 at $3.79
$190k
4.9% of stake
Aug 4, 2025No plan
Joseph M Wong
Chief Technology Officer · sold 3,052 at $5.20
$16k
0.8% of stake
Aug 4, 2025No plan
Claiborne Benson Smith
Gen Counsel, Corp Secretary · sold 2,591 at $5.20
$13k
3.0% of stake
Aug 4, 2025No plan
Stacia Hansen
Chief Accounting Officer · sold 2,742 at $5.20
$14k
3.6% of stake
Aug 4, 2025No plan
Jeremy Williamson
Chief Operating Officer · sold 1,782 at $5.20
$9k
1.3% of stake
May 23, 2025
Robert E. Rasmus
Chief Executive Officer · bought 25,000 at $4.10
$103k
2.5% of stake
May 23, 2025
Jeremy Blank
Director · bought 50,000 at $4.10
$205k
2.1% of stake
May 23, 2025
Richard Campbell-Breeden
Director · bought 75,000 at $4.10
$308k
36% of stake
May 16, 2025
Joseph M Wong
Chief Technology Officer · bought 16,000 at $4.61
$74k
4.5% of stake
May 13, 2025 – May 14, 2025
Robert E. Rasmus
Chief Executive Officer · bought 15,456 at avg $3.94
$61k
1.6% of stake
May 12, 2025
Jeremy Williamson
Chief Operating Officer · bought 400 at $4.02
$2k
0.3% of stake
May 9, 2025 – May 12, 2025
Robert E. Rasmus
Chief Executive Officer · bought 5,262 at avg $3.96
$21k
0.5% of stake
Mar 24, 2025No plan
Stacia Hansen
Chief Accounting Officer · sold 3,557 at $4.68
$17k
4.5% of stake
Mar 24, 2025No plan
Claiborne Benson Smith
Gen Counsel, Corp Secretary · sold 5,202 at $4.68
$24k
5.8% of stake
Mar 24, 2025No plan
Jeremy Williamson
Chief Operating Officer · sold 5,233 at $4.68
$24k
3.6% of stake
Mar 24, 2025No plan
Joseph M Wong
Chief Technology Officer · sold 6,596 at $4.68
$31k
1.8% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ARQ, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Miscellaneous Chemical Products

FSIFlexible Solutions International Inc.

ASPIASP Isotopes Inc.

FTKFlotek Industries Inc.

WDFCWD-40 Company

CSWCSW Industrials Inc.

AGENAgenus Inc.

NAGENiagen Bioscience Inc.

GYREGyre Therapeutics Inc.

Spot a number that looks wrong? Check it in ARQ's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ARQ

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.